GSK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 16.6%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 16.6%
Tue, 21 May

GSK PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

GSK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m7,4868,2547,512-9.0%0.3%
Other incomeRs m183164525219.5%186.7%
TurnoverRs m7,6698,4188,037-4.5%4.8%
ExpensesRs m5,9386,8805,876-14.6%-1.0%
Gross profitRs m1,5491,6551,605-3.0%3.6%
DepreciationRs m9412013713.6%46.2%
InterestRs m21160.0%-57.9%
Profit before taxRs m1,6361,6981,99217.3%21.7%
TaxRs m58156876134.0%31.1%
Profit after taxRs m1,0561,1301,2308.9%16.6%
Gross profit margin%20.720.021.4
Effective tax rate%35.533.538.2
Net profit margin%13.813.415.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 0.3% on a year-on-year (YoY) basis. The expenses were down by 1.0% YoY during the same period.
  • The company's operating profit increased by 3.6% YoY during the quarter. Consequently, operating profit margins remained same and stood at 21.4% in 4QFY19.
  • Depreciation charges increased by 46.2% and finance costs declined by 57.9% YoY, respectively.
  • Other income increased by 186.7% YoY during the quarter.
  • Net profit for the quarter increased by 16.6% YoY. Net profit margins during the quarter increased from 13.8% in 4QFY18 to 15.3% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 9.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 14.6% QoQ during the same period.
  • The company's operating profit increased by 3.0% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 21.4% in 4QFY19 as against 20.0% in 3QFY18.
  • Net profit for the quarter increased by 8.9% QoQ, while net profit margins increased from 13.4% in 3QFY18 to 15.3% in 4QFY19.

To see how GSK PHARMA has performed over the last eight quarters, please visit here.

GSK PHARMA Share Price Performance

Over the last one year, GSK PHARMA share price has moved up from Rs 1,184.1 to Rs 1,278.0, registering a Gain of Rs 93.9 or around 7.9%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,530.1 (up 1.4%). Over the last one year it has moved up from 12,686.4 to 13,530.1, a gain of 844 points (up 6.7%).

Overall, the S&P BSE SENSEX is up 13.9% over the year.

Current Valuations

At the current price of Rs 1,278.0, the price to earnings (P/E) ratio of GSK PHARMA stands at 50.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 10.5 times.

Equitymaster requests your view! Post a comment on "GSK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 16.6%". Click here!

  

Related Views on News

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Multibaggers of the Next Decade(The 5 Minute Wrapup)

Jan 6, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Jan 17, 2020 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

MARKET STATS